Abrezekimab: A Promising Breakthrough for Autoimmune Diseases ?
Abrezekimab, a novel drug, is sparking considerable excitement within the scientific community as a possible answer for managing a variety of inflammatory diseases. This monoclonal antibody works by specifically blocking a crucial molecule involved in disease progression, offering a different app